Institution
OU Health Stephenson Cancer Center
Also known as: OU Stephenson Cancer Center · OUHSC Stephenson Cancer Center · Oklahoma University Stephenson Cancer Center · Stephenson Cancer Center · Stephenson Cancer Institute · Stephenson Cancer Research Center
- 87running trials
- 42closed trials
- 3,913publications (OpenAlex)
Running trials
Not yet recruiting
Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
Recruiting
Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)
Recruiting
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
Not yet recruiting
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Not yet recruiting
Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Active, not recruiting
Recruiting
Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
Active, not recruiting
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Active, not recruiting
Active, not recruiting
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Showing 50 of 87.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer13 recruiting
- Lung cancer11 recruiting
- Endometrial cancer8 recruiting
- Colorectal cancer7 recruiting
- Head and neck cancer7 recruiting
- Bladder cancer6 recruiting
- Pancreatic cancer5 recruiting
- Prostate cancer5 recruiting
- Gastric and oesophageal cancer4 recruiting
- Cervical cancer3 recruiting
- Kidney cancer3 recruiting
- Melanoma3 recruiting
- Acute myeloid leukaemia2 recruiting
- Liver and biliary tract cancer2 recruiting
- Brain metastases1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Sarcoma1 recruiting
- Testicular cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Terminated
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Terminated
Bariatric Education for Women With Obesity and Endometrial Cancer
Terminated
Completed
Terminated
Completed
Terminated
Completed
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
Recruiting
Terminated
Terminated
Terminated
Completed
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Completed
Completed
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
Terminated
Terminated
Terminated
Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
Terminated
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors
Completed
Completed
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Terminated
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Terminated
Completed
Completed
Completed
Terminated
Completed
Completed
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Completed
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Terminated
Completed
Completed
Completed
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
Registry name variants (34)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
48 trials
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
40 trials
Oklahoma University-Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
6 trials
University of Oklahoma - Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
3 trials
Stephenson Cancer Center (chemo location)
Oklahoma City, Oklahoma 73104
2 trials
Stephenson Cancer Center (Oklahoma University)
Oklahoma City, Oklahoma 73104
2 trials
Stephenson Cancer Center, University of Oklahoma
Oklahoma City, Oklahoma 73104
2 trials
Oklahoma State University (OSU) - Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
Oklahoma University at Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
NCT05229900A Study of SGN-ALPV in Advanced Solid Tumors
Ou Health - Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
OU Health - Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
OU Health - Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
OU Health - Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
OU Health - Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
OUHSC Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
Contact: William Dooley
OU Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center at Oklahoma University
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center at OU Health
Oklahoma City, Oklahoma 73104
1 trial
NCT05548296A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Contact: Ashley Willy
Stephenson Cancer Center at OUHSC
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center at the University of Oklahoma
Oklahoma City, Oklahoma 73104
1 trial
NCT06690775CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Contact: Principal Investigator
Stephenson Cancer Center at University of Oklahoma
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center, OU Health/ Sarah Cannon Research Institute
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center (Site 0042)
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center (Site 0044)
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center (Site 0045)
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center (Site 0504)
Oklahoma City, Oklahoma 73104
1 trial
Stephenson Cancer Center, The University of Oklahoma
Oklahoma City, Oklahoma 73104
1 trial
University of Oklahoma, Stephenson Cancer Center
Oklahoma City, Oklahoma 73104-5418
1 trial
University of Oklahoma, Stephenson Cancer Center
Oklahoma City, Oklahoma 73104-5418
1 trial
University of Oklahoma, Stephenson Cancer Center
Oklahoma City, Oklahoma 73104-5418
1 trial
University of Oklahoma, Stephenson Cancer Center
Oklahoma City, Oklahoma 73104-5418
1 trial
University of Oklahoma, Stephenson Cancer Center
Oklahoma City, Oklahoma 73104-5418
1 trial
University of Oklahoma- Stephenson Oklahoma Cancer Center (Site 0055)
Oklahoma City, Oklahoma 73104
1 trial
University of Oklahoma- Stephenson Oklahoma Cancer Center (Site 1784)
Oklahoma City, Oklahoma 73104
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Ovarian cancer41 works · 33 trials
- Endometrial cancer19 works · 19 trials
- Mantle cell lymphoma6 works · 2 trials
Institution data: ROR 02bmcqd02 (CC0-1.0)Updated 15 Nov 2026